Margherita Fabbri Selected Research

Parkinson Disease (Parkinson's Disease)

4/2024	Amantadine use in the French prospective NS-Park cohort.
4/2024	Trial of Lixisenatide in Early Parkinson's Disease.
2/2024	The impact of subthalamic deep-brain stimulation in restoring motor symmetry in Parkinson's disease patients: a prospective study.
11/2023	Long-term follow-up of subthalamic nucleus deep brain stimulation in patients with Parkinson's disease: An analysis of survival and disability milestones.
11/2023	Discontinuation rate and long-term adverse events path of apomorphine infusion in advanced Parkinson's disease patients.
8/2023	Deep Brain Stimulation Outcomes in Parkinson's Disease Patients with Cognitive Impairment: Implications and Considerations.
5/2022	Personalized Care in Late-Stage Parkinson's Disease: Challenges and Opportunities.
5/2022	Efficacy of safinamide as add-on therapy after subthalamic nucleus deep brain stimulation in Parkinson disease.
3/2022	Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson's disease.
1/2022	COMT Inhibitors in the Management of Parkinson's Disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Margherita Fabbri Research Topics

Disease

40	Parkinson Disease (Parkinson's Disease) 04/2024 - 09/2014
10	Dyskinesias (Dyskinesia) 04/2024 - 10/2014
5	Disease Progression 11/2023 - 10/2014
2	Hallucinations (Hallucination) 11/2023 - 01/2020
2	Movement Disorders (Movement Disorder) 05/2022 - 12/2021
2	Pain (Aches) 05/2022 - 01/2017
2	Sleepiness 03/2022 - 01/2017
2	Orthostatic Hypotension (Postural Hypotension) 01/2022 - 01/2017
2	Parkinsonian Disorders (Parkinsonism) 12/2021 - 09/2014
2	Deglutition Disorders (Dysphagia) 01/2020 - 01/2019
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 04/2024
1	Nausea 04/2024
1	Vomiting 04/2024
1	Dementia (Dementias) 11/2023
1	Cognitive Dysfunction 08/2023
1	Autoimmune Diseases of the Nervous System 01/2023
1	Sudden Death 01/2022
1	Camptocormia 01/2022
1	Tardive Dyskinesia 12/2021
1	Huntington Disease (Huntington's Disease) 12/2021
1	Multiple System Atrophy 01/2021
1	Dysarthria (Spastic Dysarthria) 01/2019
1	Psychotic Disorders (Schizoaffective Disorder) 01/2019
1	Fatigue 01/2017
1	Body Weight (Weight, Body) 10/2014
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2014
1	Dystonia (Limb Dystonia) 07/2014
1	Autosomal Dominant Lateral Temporal Lobe Epilepsy 06/2014
1	Glioma (Gliomas) 06/2014
1	Fatal Familial Insomnia 03/2014
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 03/2014

Drug/Important Bio-Agent (IBA)

18	Levodopa (L Dopa)FDA LinkGeneric 04/2024 - 10/2014
6	Carbidopa (Lodosyn)FDA LinkGeneric 05/2021 - 08/2019
3	Amantadine (Aman)FDA LinkGeneric 04/2024 - 01/2020
3	catechol (pyrocatechol)IBA 01/2022 - 10/2016
3	TransferasesIBA 01/2022 - 10/2016
3	opicaponeIBA 01/2021 - 10/2016
2	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2017
2	safinamideIBA 05/2022 - 12/2015
2	hydroxide ionIBA 01/2022 - 01/2017
2	Tolcapone (Tasmar)FDA Link 06/2021 - 10/2016
2	neuromelaninIBA 01/2017 - 01/2017
1	Glucagon-Like Peptide-1 ReceptorIBA 04/2024
1	lixisenatideIBA 04/2024
1	Apomorphine FDA Link 11/2023
1	AutoantibodiesIBA 01/2023
1	diadenosine triphosphate (ApppA)IBA 01/2022
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 06/2021
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2021
1	SilverIBA 10/2020
1	propylene diquat (PDQ(+))IBA 01/2020
1	Delayed-Action PreparationsIBA 01/2020
1	Carboxy-LyasesIBA 10/2016
1	entacapone (Comtan)FDA Link 10/2016
1	Proteins (Proteins, Gene)FDA Link 09/2014
1	ArylsulfatasesIBA 09/2014
1	Botulinum Toxins (Botulinum Toxin)IBA 07/2014
1	Leucine (L-Leucine)FDA Link 06/2014
1	Prion ProteinsIBA 03/2014

Therapy/Procedure

11	Therapeutics 04/2024 - 07/2014
9	Deep Brain Stimulation 02/2024 - 08/2017
3	Activities of Daily Living (ADL) 11/2023 - 01/2017
2	Institutionalization (Institutionalized Persons) 11/2023 - 01/2019
1	Drug Tapering 01/2022
1	Oral Administration 01/2022
1	Physical Therapy Modalities (Physical Therapy Technique) 12/2021
1	Duration of Therapy 11/2020